Offer - Urjas Oil for just ₹ 1
Triolmesar CH 40 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Triolmesar CH 40 Tablet also has some secondary and off-label uses. These are listed below.
The right dosage of Triolmesar CH 40 Tablet depends on the age, gender, and medical history of the patient. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Common side effects of Triolmesar CH 40 Tablet include Upper respiratory tract infection, Loss of appetite, Gastric Irritation. Besides the aforementioned side effects, there are other adverse effects of Triolmesar CH 40 Tablet as well, which are listed below. Normally, these side effects of Triolmesar CH 40 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Triolmesar CH 40 Tablet's effect during pregnancy is Mild and Mild while nursing. Further, the section on Triolmesar CH 40 Tablet related warnings talks about Triolmesar CH 40 Tablet's effects on the liver, heart and kidney.
Triolmesar CH 40 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) as it can result in adverse effects. The section on Triolmesar CH 40 Tablet contraindications lists all such conditions.
Drug interactions for Triolmesar CH 40 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Triolmesar CH 40 Tablet is not safe while driving, and is is not addictive in nature.
Triolmesar CH 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Triolmesar CH 40 Tablet safe for pregnant women?
Triolmesar CH rarely shows harmful effects in in pregnant ladies. Even if it does, the effects are mild
Is the use of Triolmesar CH 40 Tablet safe during breastfeeding?
Side effects of Triolmesar CH on breastfeeding women are very mild.
What is the effect of Triolmesar CH 40 Tablet on the Kidneys?
Triolmesar CH has very mild side effects on the kidneys.
What is the effect of Triolmesar CH 40 Tablet on the Liver?
Triolmesar CH is rarely harmful for the liver.
What is the effect of Triolmesar CH 40 Tablet on the Heart?
Side effects of Triolmesar CH rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Triolmesar CH 40 Tablet unless your doctor advises you to do so -
Is this Triolmesar CH 40 Tablet habit forming or addictive?
No, there is no any evidence that Triolmesar CH 40 Tablet is addictive.
Interaction between Food and Triolmesar CH 40 Tablet
When consumed with certain foods, Triolmesar CH 40 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Triolmesar CH 40 Tablet
Consult your doctor before consuming alcohol while taking Triolmesar CH 40 Tablet as it can have severe side effects.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Thalitone ® (chlorthalidone)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 583-584
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
